Literature DB >> 3035783

Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state.

D M Mellerick, N W Fraser.   

Abstract

Herpes simplex virus (HSV) can establish latent infections in tissues of the nervous system. We have examined the HSV-1 genome in both acutely and latently infected mice by CsCl buoyant density gradient centrifugation. Viral sequences, in gradient fractions, were detected by a spot blot technique using nick-translated HSV-1 cloned DNA as probe, and mouse chromosomal DNA was located by measuring optical density at 260 nm. Most HSV-1-specific DNA from both acutely and latently infected mouse brains was found to band at the buoyant density of virion DNA. However, some HSV-1-specific hybridization banded at the density of the mouse chromosomal DNA. Further rounds of CsCl density gradient centrifugation of this chromosomal DNA from acutely infected brains released most of the HSV-1-specific hybridizing material, suggesting that the association was due to trapping. In the case of the recycled chromosomal DNA from a latent infection, all the HSV-1-specific hybridization remained chromosomal DNA associated. However, the amount of hybridization was not significantly greater in quantity than the cross-hybridization between HSV-1 and chromosomal DNA from uninfected mice. AW-Ramos, an EBV-transformed cell line containing one integrated copy of the viral genome, was centrifuged under similar conditions and showed little if any shearing; the EBV DNA banded at the density of the host cell chromosomal DNA. We conclude that the majority of the latent HSV-1 DNA exists in an extrachromosomal state in the mouse model.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035783     DOI: 10.1016/0042-6822(87)90198-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  64 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Wide variations in herpes simplex virus type 1 inoculum dose and latency-associated transcript expression phenotype do not alter the establishment of latency in the rabbit eye model.

Authors:  J E O'Neil; J M Loutsch; J S Aguilar; J M Hill; E K Wagner; D C Bloom
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 3.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

4.  Localization of herpes simplex virus type 1 DNA in latently infected BALB/c mice neurons using in situ polymerase chain reaction.

Authors:  Behzad Khansarinejad; Hoorieh Soleimanjahi; Amir Ghaemi; Taki Tiraihi; Shahram Pour Beiranvand
Journal:  Iran Biomed J       Date:  2010-07

5.  The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacetylated during latency independently of LAT transcription.

Authors:  Nicole J Kubat; Antonio L Amelio; Nicole V Giordani; David C Bloom
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

6.  Herpes simplex latency and the eye.

Authors:  J McGill
Journal:  Br J Ophthalmol       Date:  1991-11       Impact factor: 4.638

Review 7.  Immune responses to herpesviral vectors.

Authors:  Deborah A Ryan; Howard J Federoff
Journal:  Hum Gene Ther       Date:  2009-05       Impact factor: 5.695

8.  Cell culture processes for the production of viral vectors for gene therapy purposes.

Authors:  James N Warnock; Otto-Wilhelm Merten; Mohamed Al-Rubeai
Journal:  Cytotechnology       Date:  2006-06-30       Impact factor: 2.058

9.  Two open reading frames (ORF1 and ORF2) within the 2.0-kilobase latency-associated transcript of herpes simplex virus type 1 are not essential for reactivation from latency.

Authors:  M U Fareed; J G Spivack
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2.

Authors:  S W French; M C Schmidt; J C Glorioso
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.